台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

NDP046: Tumor origin of the graft ureteral cancer: From recipient or donor?

2022-06-07 • 觀看: 1467 • 回應: 0 • doc
NDP045: The graft ureteral cancer: A surgical method of graft kidney preservation and planning for future upper tract follow-up

2022-06-07 • 觀看: 1381 • 回應: 0 • doc
NDP044: Primary malignant melanoma of prostatic urethral: A rare case report and literature review

2022-06-07 • 觀看: 1326 • 回應: 0 • doc
NDP043: Comparison of chemotherapy and androgen receptor targeted agents as sequencing treatment in castration resistance prostate cancer

2022-06-07 • 觀看: 1390 • 回應: 0 • doc
NDP042: The prevalence of port-site incisional hernia after urologic robot-assisted laparoscopic surgery: A single-center retrospective study

2022-06-07 • 觀看: 1342 • 回應: 0 • doc
NDP041: Association between 5α-reductase inhibitors and androgen deprivation therapy

2022-06-07 • 觀看: 1257 • 回應: 0 • doc
NDP040: Hormone therapy for prostate cancer increased the risk of subsequent hypertension: A nationwide longitudinal cohort study

2022-06-07 • 觀看: 1291 • 回應: 0 • doc
NDP039: The risk factors of the stress urinary incontinence after robotic-assisted laparoscopic radical prostatectomy

2022-06-07 • 觀看: 1724 • 回應: 0 • doc
NDP038: The efficacy of enhanced recovery after surgery (ERAS) in radical prostatectomy

2022-06-07 • 觀看: 1447 • 回應: 0 • doc
NDP037: KCGMH experience and meta-analysis: Comparing PSA response of Abiraterone and Enzalutamide in metastatic castration-resistant prostate cancer in real-world practice

2022-06-07 • 觀看: 1509 • 回應: 0 • doc
NDP036: Female urethral hemangioma misdiagnosed as a vaginal tumor: A case report and review

2022-06-07 • 觀看: 1476 • 回應: 0 • doc
NDP035: Sertoli cell tumor of testis: Case report and review of the literature

2022-06-07 • 觀看: 1432 • 回應: 0 • doc

Prev
581
582
583
584
585
586
587
588
589
590
Next
/ 1264